You are viewing the site in preview mode

Skip to main content
Figure 2 | Clinical and Molecular Allergy

Figure 2

From: Morning versus evening dosing of desloratadine in seasonal allergic rhinitis: a randomized controlled study [ISRCTN23032971].

Figure 2

Sub-group Total Symptom Score. These sub-groups consists of patients with higher (one or more score points) morning TSS (AM last hour) than evening TSS (PM last hour) at baseline and of patients with higher evening TSS (PM last hour) than morning TSS (AM last hour) at baseline. There was no statistical significant difference in the treatment efficacy between the AM-group and the PM-group.

Back to article page

Clinical and Molecular Allergy

ISSN: 1476-7961

Contact us